Financhill
Buy
61

BKR Quote, Financials, Valuation and Earnings

Last price:
$43.71
Seasonality move :
8.38%
Day range:
$43.37 - $44.26
52-week range:
$30.93 - $49.40
Dividend yield:
1.97%
P/E ratio:
14.66x
P/S ratio:
1.57x
P/B ratio:
2.56x
Volume:
5M
Avg. volume:
7.2M
1-year change:
34.92%
Market cap:
$43.3B
Revenue:
$27.8B
EPS (TTM):
$2.98
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $20.7B $20.5B $21.2B $25.5B $27.8B
Revenue Growth (YoY) -13.14% -0.98% 3.19% 20.56% 9.11%
 
Cost of Revenues $17.5B $16.5B $16.8B $20.3B $22B
Gross Profit $3.2B $4B $4.4B $5.3B $5.8B
Gross Profit Margin 15.45% 19.75% 20.8% 20.59% 20.99%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.4B $2.5B $2.5B $2.6B $2.5B
Other Inc / (Exp) -$15.7B -$852M -$1.6B $231M $81M
Operating Expenses $2.4B $2.5B $2.5B $2.6B $2.5B
Operating Income $795M $1.6B $1.9B $2.6B $3.4B
 
Net Interest Expenses $264M $299M $252M $216M $198M
EBT. Incl. Unusual Items -$15.2B $428M $22M $2.7B $3.3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $559M $758M $600M $685M $257M
Net Income to Company -$15.8B -$330M -$578M $2B $3B
 
Minority Interest in Earnings $5.8B $111M -$23M -$27M -$29M
Net Income to Common Excl Extra Items -$9.9B -$219M -$601M $1.9B $3B
 
Basic EPS (Cont. Ops) -$14.73 -$0.27 -$0.61 $1.93 $3.00
Diluted EPS (Cont. Ops) -$14.73 -$0.27 -$0.61 $1.91 $2.98
Weighted Average Basic Share $675M $824M $987M $1B $994M
Weighted Average Diluted Share $675M $824M $987M $1B $1B
 
EBITDA -$13.6B $1.8B $1.3B $4B $4.6B
EBIT -$14.9B $727M $274M $2.9B $3.5B
 
Revenue (Reported) $20.7B $20.5B $21.2B $25.5B $27.8B
Operating Income (Reported) $795M $1.6B $1.9B $2.6B $3.4B
Operating Income (Adjusted) -$14.9B $727M $274M $2.9B $3.5B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $5.5B $5.5B $5.9B $6.8B $7.4B
Revenue Growth (YoY) -13.44% -0.18% 7.66% 15.75% 7.74%
 
Cost of Revenues $4.5B $4.3B $4.6B $5.4B $5.8B
Gross Profit $1B $1.2B $1.3B $1.4B $1.5B
Gross Profit Margin 18.36% 21.97% 22.64% 21.17% 20.78%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $574M $634M $645M $634M $585M
Other Inc / (Exp) $1.2B $211M -$283M -$246M -$98M
Operating Expenses $574M $634M $645M $634M $585M
Operating Income $435M $571M $692M $813M $945M
 
Net Interest Expenses $69M $94M $64M $45M $55M
EBT. Incl. Unusual Items $1.5B $688M $345M $522M $792M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $569M $352M $157M $71M -$399M
Net Income to Company $951M $336M $188M $451M $1.2B
 
Minority Interest in Earnings -$299M -$43M -$6M -$11M -$12M
Net Income to Common Excl Extra Items $652M $293M $182M $440M $1.2B
 
Basic EPS (Cont. Ops) $0.92 $0.33 $0.18 $0.44 $1.19
Diluted EPS (Cont. Ops) $0.91 $0.32 $0.18 $0.43 $1.18
Weighted Average Basic Share $714M $899M $999M $1B $988M
Weighted Average Diluted Share $724M $899M $999M $1B $1B
 
EBITDA $1.9B $1.1B $664M $841M $1.1B
EBIT $1.6B $782M $409M $567M $847M
 
Revenue (Reported) $5.5B $5.5B $5.9B $6.8B $7.4B
Operating Income (Reported) $435M $571M $692M $813M $945M
Operating Income (Adjusted) $1.6B $782M $409M $567M $847M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $20.7B $20.5B $21.2B $25.5B $27.8B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $17.5B $16.5B $16.8B $20.3B $22B
Gross Profit $3.2B $4B $4.4B $5.3B $5.8B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.4B $2.5B $2.5B $2.6B $2.5B
Other Inc / (Exp) -$15.7B -$852M -$1.6B $232M $82M
Operating Expenses $2.4B $2.5B $2.5B $2.6B $2.5B
Operating Income $795M $1.6B $1.9B $2.6B $3.4B
 
Net Interest Expenses $263M $300M $253M $216M $198M
EBT. Incl. Unusual Items -$15.2B $427M $21M $2.7B $3.3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $559M $757M $599M $685M $257M
Net Income to Company -$15.8B -$330M -$578M $2B $3B
 
Minority Interest in Earnings $5.8B $111M -$24M -$26M -$30M
Net Income to Common Excl Extra Items -$9.9B -$219M -$602M $1.9B $3B
 
Basic EPS (Cont. Ops) -$15.29 -$0.35 -$0.60 $1.93 $3.00
Diluted EPS (Cont. Ops) -$15.30 -$0.36 -$0.60 $1.91 $2.98
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -$13.6B $1.8B $1.3B $4B $4.6B
EBIT -$14.9B $727M $274M $2.9B $3.5B
 
Revenue (Reported) $20.7B $20.5B $21.2B $25.5B $27.8B
Operating Income (Reported) $795M $1.6B $1.9B $2.6B $3.4B
Operating Income (Adjusted) -$14.9B $727M $274M $2.9B $3.5B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $20.5B $21.2B $25.5B $27.8B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $16.5B $16.8B $20.3B $22B --
Gross Profit $4B $4.4B $5.3B $5.8B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.5B $2.5B $2.6B $2.5B --
Other Inc / (Exp) -$852M -$1.6B $232M $82M --
Operating Expenses $2.5B $2.5B $2.6B $2.5B --
Operating Income $1.6B $1.9B $2.6B $3.4B --
 
Net Interest Expenses $300M $253M $216M $198M --
EBT. Incl. Unusual Items $427M $21M $2.7B $3.3B --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $757M $599M $685M $257M --
Net Income to Company -$330M -$578M $2B $3B --
 
Minority Interest in Earnings $111M -$24M -$26M -$30M --
Net Income to Common Excl Extra Items -$219M -$602M $1.9B $3B --
 
Basic EPS (Cont. Ops) -$0.35 -$0.60 $1.93 $3.00 --
Diluted EPS (Cont. Ops) -$0.36 -$0.60 $1.91 $2.98 --
Weighted Average Basic Share $3.3B $3.9B $4B $4B --
Weighted Average Diluted Share $3.3B $4B $4.1B $4B --
 
EBITDA $1.8B $1.3B $4B $4.6B --
EBIT $727M $274M $2.9B $3.5B --
 
Revenue (Reported) $20.5B $21.2B $25.5B $27.8B --
Operating Income (Reported) $1.6B $1.9B $2.6B $3.4B --
Operating Income (Adjusted) $727M $274M $2.9B $3.5B --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $4.1B $3.9B $2.5B $2.6B $3.4B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $4.7B $4.7B $5.1B $6B $5.9B
Inventory $4.4B $4B $4.6B $5.1B $5B
Prepaid Expenses -- -- -- -- --
Other Current Assets $2.3B $1.6B $1.6B $1.5B $1.8B
Total Current Assets $16.5B $15.1B $14.6B $16.3B $17.2B
 
Property Plant And Equipment $5.4B $4.9B $4.5B $4.9B $5.1B
Long-Term Investments -- -- -- -- --
Goodwill $6B $6B $5.9B $6.1B $6.1B
Other Intangibles $4.4B $4.1B $4.2B $4.1B $4B
Other Long-Term Assets $2.9B $2.9B $2.8B $3B $3B
Total Assets $38B $35.3B $34.2B $36.9B $38.4B
 
Accounts Payable $3.5B $3.7B $4.3B $4.5B $4.5B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt $88M $40M $29M $39M $53M
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $2.4B $2.1B $2.3B $2.8B $2.7B
Total Current Liabilities $10.2B $9.1B $11.1B $13B $13B
 
Long-Term Debt $6.7B $6.7B $6B $5.9B $6B
Capital Leases -- -- -- -- --
Total Liabilities $19.8B $18.6B $19.7B $21.4B $21.3B
 
Common Stock -- -- -- -- --
Other Common Equity Adj -$1.8B -$2.4B -$3B -$2.8B -$3.2B
Common Equity $12.9B $14.8B $14.4B $15.4B $16.9B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $5.3B $1.9B $131M $151M $160M
Total Equity $18.2B $16.7B $14.5B $15.5B $17.1B
 
Total Liabilities and Equity $38B $35.3B $34.2B $36.9B $38.4B
Cash and Short Terms $4.1B $3.9B $2.5B $2.6B $3.4B
Total Debt $7.6B $6.7B $6.7B $6B $6B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $4.1B $3.9B $2.5B $2.6B $3.4B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $4.7B $4.7B $5.1B $6B $5.9B
Inventory $4.4B $4B $4.6B $5.1B $5B
Prepaid Expenses -- -- -- -- --
Other Current Assets $2.3B $1.6B $1.6B $1.5B $1.8B
Total Current Assets $16.5B $15.1B $14.6B $16.3B $17.2B
 
Property Plant And Equipment $5.4B $4.9B $4.5B $4.9B $5.1B
Long-Term Investments -- -- -- -- --
Goodwill $6B $6B $5.9B $6.1B $6.1B
Other Intangibles $4.4B $4.1B $4.2B $4.1B $4B
Other Long-Term Assets $2.9B $2.9B $2.8B $3B $3B
Total Assets $38B $35.3B $34.2B $36.9B $38.4B
 
Accounts Payable $3.5B $3.7B $4.3B $4.5B $4.5B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt $88M $40M $29M $39M $53M
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $2.4B $2.1B $2.3B $2.8B $2.7B
Total Current Liabilities $10.2B $9.1B $11.1B $13B $13B
 
Long-Term Debt $6.7B $6.7B $6B $5.9B $6B
Capital Leases -- -- -- -- --
Total Liabilities $19.8B $18.6B $19.7B $21.4B $21.3B
 
Common Stock -- -- -- -- --
Other Common Equity Adj -$1.8B -$2.4B -$3B -$2.8B -$3.2B
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $5.3B $1.9B $131M $151M $160M
Total Equity $18.2B $16.7B $14.5B $15.5B $17.1B
 
Total Liabilities and Equity $38B $35.3B $34.2B $36.9B $38.4B
Cash and Short Terms $4.1B $3.9B $2.5B $2.6B $3.4B
Total Debt $7.6B $6.7B $6.7B $6B $6B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$15.8B -$330M -$578M $2B $3B
Depreciation & Amoritzation $1.3B $1.1B $1.1B $1.1B $1.1B
Stock-Based Compensation $210M $205M $207M $197M $202M
Change in Accounts Receivable $611M $136M -$701M -$1.2B -$255M
Change in Inventories -$80M $170M -$885M -$461M -$102M
Cash From Operations $1.3B $2.4B $1.9B $3.1B $3.3B
 
Capital Expenditures $974M $856M $989M $1.2B $1.3B
Cash Acquisitions $130M -$17M -$767M -$8M --
Cash From Investing -$618M -$463M -$1.6B -$817M -$1B
 
Dividends Paid (Ex Special Dividend) -$744M -$749M -$726M -$786M -$836M
Special Dividend Paid
Long-Term Debt Issued $1.2B $1.3B -- -- --
Long-Term Debt Repaid -$246M -$2.1B -- -$651M -$143M
Repurchase of Common Stock -- -$434M -$828M -$538M -$484M
Other Financing Activities -$22M -$65M -$38M -$53M -$64M
Cash From Financing $225M -$2.1B -$1.6B -$2B -$1.5B
 
Beginning Cash (CF) $3.2B $4.1B $3.9B $2.5B $2.6B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $911M -$232M -$1.3B $217M $789M
Ending Cash (CF) $4.1B $3.9B $2.5B $2.6B $3.4B
 
Levered Free Cash Flow $330M $1.5B $899M $1.8B $2.1B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $951M $336M $188M $451M $1.2B
Depreciation & Amoritzation $307M $273M $255M $274M $292M
Stock-Based Compensation -- -- $52M $49M $48M
Change in Accounts Receivable $122M -$350M -$135M -$460M -$296M
Change in Inventories $103M $19M -$259M -$51M $48M
Cash From Operations $377M $774M $898M $932M $1.2B
 
Capital Expenditures $173M $266M $269M $356M $353M
Cash Acquisitions -- -- -$681M -- --
Cash From Investing -$67M -$251M -$984M -$314M -$217M
 
Dividends Paid (Ex Special Dividend) -$186M -$186M -$190M -$200M -$208M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $737M -- -- -- --
Long-Term Debt Repaid -$76M -$1.3B -- -$651M -$9M
Repurchase of Common Stock -- -$328M -$101M -$319M -$8M
Other Financing Activities -$7M -$41M -$4M $3M -$9M
Cash From Financing -$269M -$558M -$295M -$1.2B -$234M
 
Beginning Cash (CF) $4.1B $3.9B $2.9B $3.2B $2.7B
Foreign Exchange Rate Adjustment $30M -$38M $18M -$6M -$39M
Additions / Reductions $41M -$35M -$381M -$549M $739M
Ending Cash (CF) $4.1B $3.9B $2.5B $2.6B $3.4B
 
Levered Free Cash Flow $204M $508M $629M $576M $837M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$15.8B -$330M -$578M $2B $3B
Depreciation & Amoritzation $1.3B $1.1B $1.1B $1.1B $1.1B
Stock-Based Compensation -- -- $207M $197M $202M
Change in Accounts Receivable $611M $136M -$701M -$1.2B -$255M
Change in Inventories -$80M $170M -$885M -$461M -$102M
Cash From Operations $1.3B $2.4B $1.9B $3.1B $3.3B
 
Capital Expenditures $974M $856M $989M $1.2B $1.3B
Cash Acquisitions -- -- -$767M -$8M --
Cash From Investing -$618M -$463M -$1.6B -$817M -$1B
 
Dividends Paid (Ex Special Dividend) -$744M -$749M -$726M -$786M -$836M
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$246M -$2.1B -- -- --
Repurchase of Common Stock -- -$434M -$828M -$538M -$484M
Other Financing Activities -$22M -$65M -$38M -$53M -$64M
Cash From Financing $225M -$2.1B -$1.6B -$2B -$1.5B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $911M -$232M -$1.3B $217M $789M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $330M $1.5B $899M $1.8B $2.1B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders -$330M -$578M $2B $3B --
Depreciation & Amoritzation $1.1B $1.1B $1.1B $1.1B --
Stock-Based Compensation -- $207M $197M $202M --
Change in Accounts Receivable $136M -$701M -$1.2B -$255M --
Change in Inventories $170M -$885M -$461M -$102M --
Cash From Operations $2.4B $1.9B $3.1B $3.3B --
 
Capital Expenditures $856M $989M $1.2B $1.3B --
Cash Acquisitions -- -$767M -$8M -- --
Cash From Investing -$463M -$1.6B -$817M -$1B --
 
Dividends Paid (Ex Special Dividend) -$749M -$726M -$786M -$836M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$2.1B -- -$651M -$143M --
Repurchase of Common Stock -$434M -$828M -$538M -$484M --
Other Financing Activities -$65M -$38M -$53M -$64M --
Cash From Financing -$2.1B -$1.6B -$2B -$1.5B --
 
Beginning Cash (CF) $16.4B $12.8B $10.9B $10.3B --
Foreign Exchange Rate Adjustment -$47M -$97M -$59M -$71M --
Additions / Reductions -$232M -$1.3B $217M $789M --
Ending Cash (CF) $16.1B $11.5B $11.1B $11B --
 
Levered Free Cash Flow $1.5B $899M $1.8B $2.1B --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Pepsi Vs Coke Stock: Which Is Best?
Pepsi Vs Coke Stock: Which Is Best?

Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 18

Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.

Buy
63
EXOD alert for Mar 19

Exodus Movement [EXOD] is down 3.96% over the past day.

Sell
45
MNPR alert for Mar 18

Monopar Therapeutics [MNPR] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock